CAR-TCR Summit coverage to track novel CAR-T Cell Therapies for B-Cell Malignancies

Scope & Objective:

A large US base Pharma Company, wanted DelveInsight to support them by providing a detailed CAR-TCR Summit coverage of novel CAR-T Cell Therapies for the B-Cell Malignancies, including the emerging product analysis, developmental activities, safety and efficacy data, product milestones, future plans and KOL insights.

Congress Coverage Support:

• DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the novel CAR-T Cell Therapies
• In addition to this DelveInsight also conducted primary research in order to cater the KOL and Stakeholder insights around the cell therapy
• High-priority sessions were selected for more focused live coverage

Congress Plan:

• The team extracted and classified sessions by priorities
• Captured detailed presentations and understand the business insights
• KITs and KIQs were aligned with the client’s strategic needs

Outcome:

• The deliverables enabled the client to proactive response to competitor activities in the B-Cell Malignancies disease area presented at CAR_TCR Summit
• Senior internal stakeholders were timely informed of the latest business updates